Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

Inclusion Criteria

• •A male or female subject greater than or equal to 15 years of age at the time of study entry
• •Written informed consent obtained from the subject/ from the parent or guardian of the subject.
• •Seronegative for anti-HBc antibodies and for HBsAg at screening.
• •Pre-dialysis patients, peritoneal dialysis patients or haemodialysis patients
• •Documented evidence of previous hepatitis B vaccination with at least one full primary vaccination course of minimum four injections of licensed vaccine.
• •The last dose should have been administered at least two months before the planned first dose of study vaccine in this study.
• •Documented evidence of non-response to previous hepatitis B vaccination after at least one to maximum three months after the last vaccine dose.